Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Patrick Weik"'
Autor:
Christoph B Olivier, Melanie Meyer, Hans Bauer, Katharina Schnabel, Patrick Weik, Qian Zhou, Christoph Bode, Martin Moser, Philipp Diehl
Publikováno v:
PLoS ONE, Vol 11, Iss 2, p e0149053 (2016)
This study aimed to assess the association of clinical factors with P2Y12-dependent platelet inhibition as monitored by the ratio of ADP- to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively.Controversial findin
Externí odkaz:
https://doaj.org/article/f8c8aeb2ed9a4448a35059dcb4f2482a
Autor:
Christoph Bode, Qian Zhou, Melanie Meyer, Christoph B. Olivier, Martin Moser, Susanne Weber, Patrick Weik, Philipp Diehl
Publikováno v:
Journal of Thrombosis and Thrombolysis. 42:161-166
Dabigatran and rivaroxaban are novel, vitamin K-independent oral anticoagulants (NOACs) and act via antagonism of the coagulation factor (F) IIa (dabigatran) or FXa (rivaroxaban), respectively. Compared to vitamin-K-antagonists, NOACs have shown non-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1756ae336f0eb520dfbdfd0c26e79904
https://doi.org/10.1007/s11239-016-1350-7
https://doi.org/10.1007/s11239-016-1350-7
Autor:
Philipp Diehl, Melanie Meyer, Qian Zhou, Ulrich Geisen, Patrick Weik, Nathaly Anto-Michel, Christoph Bode, Susanne Weber, Christoph B. Olivier, Martin Moser
Publikováno v:
Thrombosis Research. 138:63-68
Novel (or non-vitamin K antagonist) oral anti-coagulants (NOACs) are antagonists of coagulation factors (F) Xa (rivaroxaban) or IIa (dabigatran), and their non-inferiority compared with vitamin K antagonists has been demonstrated in patients with non
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e19e77a78dcd5a6558ee7f4a8384906
https://doi.org/10.1016/j.thromres.2015.10.038
https://doi.org/10.1016/j.thromres.2015.10.038
Autor:
Christoph Brandt, Manfred Olschewski, Qian Zhou, Philipp Diehl, Martin Moser, Christoph Bode, Katharina Schnabel, Patrick Weik, Christoph B. Olivier
Publikováno v:
Clinical Research in Cardiology. 103:968-975
This study aimed to evaluate whether a high relative ADP induced aggregation (r-ADP-agg) is associated with an increased mortality in patients after coronary stent implantation. Several trials were not able to improve clinical outcome by adapting pla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb3f61870c66de88f0cbed7e6c39225c
https://doi.org/10.1007/s00392-014-0737-8
https://doi.org/10.1007/s00392-014-0737-8
Autor:
Qian Zhou, Patrick Weik, Martin Moser, Christoph Bode, Christoph B. Olivier, Philipp Diehl, Katharina Schnabel
Publikováno v:
Thrombosis and Haemostasis. 112:266-272
SummaryThe current standard of antiplatelet therapy of patients after myocardial infarction includes the P2Y12 receptor antagonists clopidogrel, prasugrel or ticagrelor. This study aimed to compare the antiplatelet effect of clopidogrel, prasugrel an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a44bac76b079dcb2b645663c96a55125
https://doi.org/10.1160/th13-06-0508
https://doi.org/10.1160/th13-06-0508
Autor:
Philipp Diehl, Katharina Schnabel, Patrick Weik, Anne Charlet, Jennifer S. Esser, Christoph Bode, Jonathan Rilinger, Melanie Meyer, Qian Zhou, Martin Moser, Christoph B. Olivier
Publikováno v:
Journal of thrombosis and thrombolysis. 42(4)
High platelet reactivity (HPR) after P2Y12-inhibition in patients undergoing coronary stenting is associated with an increased risk for thromboembolic events and coronary death. So far it is not known how HPR affects the clinical outcome of different
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2866762c261f1d8a8998b32720d24c2
https://pubmed.ncbi.nlm.nih.gov/27387715
https://pubmed.ncbi.nlm.nih.gov/27387715
Autor:
Christoph B Olivier, Melanie Meyer, Hans Bauer, Katharina Schnabel, Patrick Weik, Qian Zhou, Christoph Bode, Martin Moser, Philipp Diehl
Publikováno v:
PLoS ONE
PLoS ONE, Vol 11, Iss 2, p e0149053 (2016)
PLoS ONE, Vol 11, Iss 2, p e0149053 (2016)
Objective This study aimed to assess the association of clinical factors with P2Y12-dependent platelet inhibition as monitored by the ratio of ADP- to TRAP-induced platelet aggregation and conventional ADP-induced aggregation, respectively. Backgroun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::fd0437f036804ec659ae07c8ad1dad1b
https://pubmed.ncbi.nlm.nih.gov/26885820
https://pubmed.ncbi.nlm.nih.gov/26885820